HeMemics Biotechnologies
PRIVATE
STATUS
Later Stage VC
LATEST DEAL TYPE
5
INVESTORS
Description
Developer of a cell preservation platform designed to dehydrate biologics in dried or partially dried format for wider distribution and ease of use. The company's platform allows preserving of mammalian cells and biologics in desiccated and non-desiccated formats in cold or ambient temperature instead of frozen format, enabling medical practitioners to stabilize biologics in a dried or partially dried format for less damage to proteins or cells, ease of storage, transport and extended shelf-life.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
- 9700 Great Seneca Highway
- Rockville, MD 20850
- United States
+1 (301) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore HeMemics Biotechnologies’s full profile, request a free trial.
HeMemics Biotechnologies Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 15-May-2019 | 00.000 | Completed | Generating Revenue | ||
| 5. Seed Round | 15-Oct-2018 | 00.00 | 00.000 | 00.00 | Completed | Startup |
| 4. Angel (individual) | 25-May-2018 | 00000 | 00000 | Completed | Startup | |
| 3. Accelerator/Incubator | 01-Dec-2017 | 00000 | Completed | Startup | ||
| 2. Grant | 01-Jan-2012 | $185K | $107K | Completed | Startup | |
| 1. Accelerator/Incubator | 13-Aug-2007 | $107K | $107K | Completed | Startup |
HeMemics Biotechnologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 2 | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Seed 1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
HeMemics Biotechnologies Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Inova Strategic Investments | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Inova Personalized Health Accelerator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | |||
| Maryland Industrial Partnerships | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| TEDCO | Venture Capital | Minority | 000 0000 | 000000 0 |
HeMemics Biotechnologies Executive Team (6)
You’re viewing 5 of 6 executives. Get the full list »HeMemics Biotechnologies Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Bruce Campbell | HeMemics Biotechnologies | President & Board Member | 000 0000 | |
| David Ho Ph.D | HeMemics Biotechnologies | Co-Founder, President, Chief Executive Officer & Board Member | 000 0000 | |
| James Hogarty | HeMemics Biotechnologies | Executive Officer & Board Member | 000 0000 | |
| Larry Simpson | HeMemics Biotechnologies | Board Member | 000 0000 | |
| Roger Brook | HeMemics Biotechnologies | Executive Officer & Board Member | 000 0000 |